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Structural brain magnetic resonance imaging (MRI) traits share part of their genetic variance 
with cognitive traits. Here, we use genetic association results from large meta-analytic 
studies of genome-wide association for brain infarcts, white matter hyperintensities, 
intracranial, hippocampal and total brain volumes to estimate polygenic scores for these 
traits in three Scottish samples: Generation Scotland: Scottish Family Health Study 
(GS:SFHS), and the Lothian Birth Cohorts of 1936 (LBC1936) and 1921 (LBC1921). These five 
brain MRI trait polygenic scores were then used to 1) predict corresponding MRI traits in the 
LBC1936 (numbers ranged 573 to 630 across traits) and 2) predict cognitive traits in all three 
cohorts (in 8,115 to 8,250 persons). In the LBC1936, all MRI phenotypic traits were 
correlated with at least one cognitive measure; and polygenic prediction of MRI traits was 
observed for intracranial volume. Meta-analysis of the correlations between MRI polygenic 
scores and cognitive traits revealed a significant negative correlation (maximal r=0.08) 
between the hippocampal volume polygenic score and measures of global cognitive ability 
collected in childhood and in old age in the Lothian Birth Cohorts. The lack of association to 
a related general cognitive measure when including the GS:SFHS points to either type 1 
error or the importance of using prediction samples that closely match the demographics of 
the genome-wide association samples from which prediction is based. Ideally, these 
analyses should be repeated in larger samples with data on both MRI and cognition, and 
using MRI GWA results from even larger meta-analysis studies. 
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Structural brain MRI traits and cognitive abilities are heritable, with over 50% of the 
variance for some MRI traits, e.g, frontal lobe volumes and white matter hyperintensities, 
being due to genes (Deary et al. 2009; Peper et al. 2007). Some of these MRI traits have 
been shown to share genetic variance with cognitive measures (Betjemann et al. 2010; 
Bohlken et al. 2014; Posthuma et al. 2002). Here, we test whether the additive effect of 
common DNA single nucleotide polymorphisms (SNPs) influencing cerebral white matter 
hyperintensities burden (WMH), brain infarcts (BI), hippocampal (HV), total brain (TBV) and 
intracranial (ICV) volumes predict variance in measures of cognitive ability. These MRI 
polygenic scores will be based on the results of four genome-wide association (GWA) 
studies (Bis et al. 2012; Debette et al. 2010; Fornage et al. 2011; Ikram et al. 2012), and 
estimated in three Scottish cohorts who have been measured on processing speed, 
memory, verbal and executive function. Firstly, we will establish whether the brain MRI 
polygenic scores predict their respective MRI trait in one of the cohorts who have MRI data. 
Where this is confirmed, we expect that common SNPs influencing these MRI traits will 
explain variance in the cognitive traits.  
Various brain MRI structural traits are associated with cognitive ability (Andreasen et 
al. 1993; Haier et al. 2004). The most investigated of these is TBV, which correlates 0.33 
with intelligence, as estimated from a meta-analysis of 37 samples (n=1530) (McDaniel 
2005). Twin studies have supported complete genetic mediation of this relationship in 
adults (Posthuma et al. 2002); and in children, genetic overlap has been shown between 
measures of TBV, neocortex, white matter and prefrontal cortex with a range of cognitive 
indices (IQ, reading ability, processing speed) (Betjemann et al. 2010). ICV, which might be 
considered as a premorbid/maximal brain size measure, has been associated with 
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vocabulary performance (Schottenbauer et al. 2007), and with semantic memory, executive 
function and spatial ability when adjusting for current brain pathology in older people 
(Farias et al. 2012). HV has largely been investigated in relation to memory abilities. A meta-
analysis of 33 studies reporting correlations between HV and memory performance showed 
a negative correlation of 0.25 for children and young adult samples, and a positive 
correlation (0.10) in older samples (Van Petten 2004). Heterogeneity within older sample 
estimates indicated a variable association dependent on age-related changes, possibly 
influenced more by environmental factors, which have a greater effect on HV in old age 
than do genes (Sullivan et al. 2001).  
Other brain MRI traits have shown significant associations with particular cognitive 
domains or in specific demographic groups. WMH, for example, are mainly associated with 
impaired executive functioning, particularly in ageing populations where WMH are more 
prevalent (Farias et al. 2012; Gunning-Dixon & Raz 2000; Hedden et al. 2012). A twin study 
of older men showed that 70-100% of the correlation between WMH and cognitive traits 
was due to common genes (Carmelli et al. 2002). BIs are also related to cognitive 
dysfunction and decline in the elderly, with rates being increased even in persons with 
covert BI in the absence of clinical stroke events (Vermeer et al. 2003). The genetic 
underpinning of this relationship is unknown.  
The genetic covariance between brain MRI and cognitive traits provides the rationale 
for our investigation which aims to establish whether the variability in cognition can be 
partly explained by structural brain differences. No common genes of large effect (e.g., >5% 
variance) have been reported for brain MRI traits. Therefore, we create brain MRI polygenic 
scores based on the summative influence of SNPs with differing levels of effect size (i.e., 
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from significant to non-significant effects) from recent GWA meta-analysis studies (Bis et al. 
2012; Debette et al. 2010; Fornage et al. 2011; Ikram et al. 2012). We test whether these 
polygenic scores are predictive of 1) their respective MRI trait, and 2) of cognitive variation. 
Material and Methods 
Cohorts 
Brain MRI polygenic profile scores were calculated in three independent Scottish cohorts: 
Generation Scotland: Scottish Family Health Study (GS:SFHS), the Lothian Birth Cohort 1936 
(LBC1936), and the Lothian Birth Cohort 1921 (LBC1921). GS:SFHS is a large population 
family-based study of around 24,000 Scottish participants sampled between the years 2006 
and 2011 (www.generationscotland.org/); 10,000 participants were selected for genome-
wide analysis based on: Caucasian ethnicity, being born in the UK, and full phenotype data 
(Kerr et al. 2013). In the current analysis only unrelated subjects were included, leaving an 
analysis sample of 6,814. The mean age of the sample was 55.5 years (SD=11.4) at testing 
(59% women). The LBC samples comprise relatively healthy individuals born in 1921 or 1936 
in the Edinburgh area, most of whom had completed the Moray House Test No. 12 (MHT) 
assessment of general intelligence in the Scottish Mental Surveys of 1932 or 1947 at a mean 
age of 11 years (Deary et al. 2012). The LBC1936 (n=1091; 49.8% women) were tested on 
the MHT and other cognitive measures in adulthood at a mean age of 69.5 years (SD=0.8). 
At age 73, a subset of these individuals (n=724) underwent structural MRI. The LBC1921 
(n=550; 57.4% women) completed the MHT plus additional cognitive tests at a mean age of 
79.1 years (SD=0.6) and later at 83.3 years (SD=0.54). Following informed consent, 
venesected whole blood was collected for DNA extraction for the LBC samples with both 
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saliva and blood being used for DNA extraction in the GS:SFHS. Ethical approval for the LBCs 
was obtained from Scotland’s Multicentre Research Ethics Committee and local research 
ethics committee. GS:SFHS ethical approval was granted by the NHS Tayside Committee on 
Medical Research Ethics (REC Reference Number: 05/S1401/89). Research Tissue Bank 
status was approved by the Tayside Committee on Medical Research Ethics (REC Reference 
Number: 10/S1402/20), enabling generic ethical approval for medical research purposes. 
MRI measures in LBC1936 
Structural T2-, T2*-, FLAIR- and T1-weight brain MRI data were collected using a GE Signa 
1.5 T HDXT clinical scanner. BIs were coded for size and location based on vascular territory 
and typical signal characteristics by consultant neuroradiologists using a validated stroke 
lesion rating scale (Wardlaw et al. 2011; Wardlaw & Sellar 1994) which differentiates 
infarcts into cortical, lacunar, borderzone and brainstem/cerebellar. Lacunar infarcts were 
coded as being cavitated or not (Wardlaw et al. 2013). BI of any size and location were 
present in 93 individuals and absent in 537. WMH measured in the white matter, subcortical 
grey matter including cerebellum and brainstem were quantified semi-automatically with 
MCMxxxVI (Hernandez Mdel et al. 2010). Images were inspected and false positive and 
negative lesions manually corrected 
(http://www.bric.ed.ac.uk/research/imageanalysis.html). Focal stroke lesions were masked 
manually to distinguish them from other structures. The dependent measure was the 
natural logarithm(WMH burden in mL +1). ICV includes the contents within the inner skull 
table including venous sinuses and has its inferior limit in the axial slice just superior to the 
tip of the odontoid peg at the foramen magnum and superior to the inferior limits of the 
cerebellar tonsils. The ICV was obtained semi-automatically using the T2*W sequence. The 
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first approximation of the ICV was obtained automatically using the Object Extraction Tool 
in Analyze 9.0. Then, the cervical spinal cord inferior to the inferior boundary was removed 
manually, along with the pituitary gland (in cases where this latter structure was included). 
HV was obtained after an automatic segmentation of left and right hippocampi using FSL 
tools (www.fmrib.ox.ac.uk/fsl) and an ageing template. The resulting automatically 
segmented masks were visually assessed for accuracy, and manually edited using Analyze 
9.0 (Mayo Clinic, AnalyzeDirect, Inc. Mayo Clinic) if required. Mean of left and right 
hippocampal volumes was used. TBV (mm3) was defined by the volume of the cerebrospinal 
fluid, venous sinuses and meninges subtracted from the ICV. To correct for variation in head 
size between individuals, HV and TBV were expressed as percentages of ICV.  
Cognitive measures collected in all cohorts 
In GS:SFHS, four cognitive ability tests were administered: the Wechsler Digit Symbol 
Substitution Test (DS), Wechsler Memory Scale Logical Memory Test (sum of immediate and 
delayed recall of one paragraph) (LM), the phonemic Verbal Fluency Test using the letters C, 
F, and L, each for one minute (VF), and the Mill Hill Vocabulary Scale combining junior and 
senior synonyms (MHV) (Smith et al. 2006). In the LBC samples, DS, LM and VF tests were 
administered, but instead of the MHV, the National Adult Reading Test (NART) (Nelson 
1982) was used to index vocabulary ability. For the LBC1921, DS was only measured at age 
83 years, where the sample size was reduced (n=302). A composite score of these four 
measures (or 3 age 79 measures for the LBC1921) was formed by deriving regression-based 
factor scores from an unrotated principal components analysis which explained 45%-55.3% 
of variance across cohorts. In addition to these four overlapping tests across the three 
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cohorts, LBC samples had overlapping MHT scores from childhood (MHT11) and old-age 
(MHT).  
Genotyping 
Genotyping in the GS:SFHS and LBC samples was performed at the Wellcome Trust Clinical 
Research Facility Genetics Core, Edinburgh (www.wtcrf.ed.ac.uk). GS:SFHS samples were 
genotyped on the Illumina HumanOmniExpressExome-8 v1.0 DNA Analysis BeadChip using 
Infinium chemistry (Marioni et al. 2014). In the LBC samples, Illumina Human610-Quadv1 
Chip whole genome genotyping was available. Genotype quality control procedures are 
described elsewhere (Davies, 2011), but briefly, necessary exclusion were made for gender 
discrepancies, individual relatedness, and non-Caucasian descent. Good quality genotyping 
information was available for 509 (LBC1921) and 1005 (LBC1936) Caucasian individuals. 
Statistical Analysis 
Five sets of brain MRI polygenic scores—BI, WMH, ICV, TBV, and HV—were estimated using 
SNP association results from GWA meta-analyses of the Cohorts for Heart and Aging 
Research in Genomic Epidemiology (CHARGE) consortium (Bis et al. 2012; Debette et al. 
2010; Fornage et al. 2011; Ikram et al. 2012). In these studies, GWA was performed using 
HapMap release 22, Build 36 imputed data in Caucasian samples ranging in size from 8175 
(mean age 67.5 ±7.7 years) to 9401 (the mean age of each of the contributing cohorts was 
as follows: 76.2 ±5.4, 63.2 ±4.4, 65.3 ±8, 71.7 ±4.8, 63.9 ±11.3, 72.9 ±7.9, and 67.2 ±5.3). See 
Supplementary Table 1 (available on the Cambridge Journals Online website) for a 
comparison of age characteristics with the prediction cohorts. 
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A series of brain MRI polygenic scores were estimated in the GS:SFHS and LBC samples by 
inclusion of SNPs with varying association p-values—p<0.01, p<0.05, p<0.1, p<0.5, p<1—
from the GWA meta-analyses. These scores were calculated on observed genotype data 
using the profile scoring function in PLINK software (Purcell et al. 2007) and represented the 
sum of individual SNP effects whereby the meta-analytic effect size (Z-score/beta) was 
weighted by the number of copies (0/1/2) of the effect allele carried by the individual. Prior 
to calculating these scores, exclusions of SNP data were made in the three cohorts for: 
minor allele frequency <0.05, Hardy-Weinberg Equilibrium test <px10-7, and strand 
ambiguity (AT and GC SNPS). To minimise any bias caused by correlated SNPs entering the 
polygenic score, remaining SNPs were pruned for linkage disequilibrium based on r2 being 
less than 0.25 within a 200-SNP sliding window. As part of profile scoring, the remaining 
SNPs were then matched with those from the GWA meta-analysis results. Whereas the 
GWA results were for ~2.5 million SNPs, only a subset of these (at most ~112,000) were 
used in polygenic score estimation. Supplementary Table 2 shows the number of SNPs 
included in the calculation of the polygenic scores. In the polygenic score calculation, 
missing genotypes for any individual were imputed based on the observed SNP allele 
frequency in the cohort.  
Multiple regression was used to test the association between brain MRI polygenic scores 
and brain MRI traits in the LBC1936. Predictors included: brain MRI polygenic score, age at 
MRI scan, sex, three population stratification principal components (seeDavies et al. 2011), 
and the number of non-missing SNPs forming the score for each individual (less reliable 
polygenic scores will be formed for individuals with a greater amount of missing data). The 
dependent measure was the MRI trait corresponding with the MRI polygenic score in the 
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prediction model. ICV was additionally entered as a covariate in the analysis of WMH in line 
with the GWA study of WMH (Fornage et al. 2011). Sensitivity analyses for all MRI 
dependent measures were performed by excluding 43 individuals with self-reported stroke. 
The LBC1936 was a relatively healthy sample (no self-reported dementia) and consistent 
with the previous GWA studies we do not adjust for other genotypes such as APOE. 
Regression analyses were performed for polygenic scores at each SNP inclusion criterion 
(p<0.01, p<0.05, p<0.1, p<0.5, p<1). Because the polygenic scores at different SNP inclusion 
are non-independent, we made a Bonferroni correction to our alpha level of .05 for the five 
polygenic MRI traits, which gave an adjusted significance level of .01.  
 For the cognitive measures, similar regression models were tested, but with age at MRI 
scanning replaced by age at cognitive test. Standardised betas from the regression models 
for the cognitive traits were meta-analysed under a random effects model in R (MAc 
package) (R Development Core Team 2008) giving an overall effect size and standard error. 
Given the inter-correlations among the four cognitive tests and among the five MRI 
polygenic traits we made an alpha-level adjustment based on a matrix spectral 
decomposition (Nyholt, 2005) of these traits (g was not included because it is a composite 
measure of the cognitive tests, and we chose one polygenic score (p<1 inclusion threshold) 
to avoid dependency among polygenic scores at differing SNP p-value inclusion levels).  
Using the largest cohort, GS:SFHS, we identified 8.86 effective traits to give an adjusted 
alpha level of .006. Heterogeneity between sample estimates was tested via Cochran’s Q 
statistic.  
Results 
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Polygenic prediction of MRI traits in the LBC1936 
The sample size varied between 573 (WMH) and 629 (BI).  ICV was the only variable to show 
significant associations at the corrected alpha level (p<0.01); correlations ranged 0.08-0.10 
across all p-value polygenic inclusion criteria (Supplementary Table 4). The HV polygenic 
score was most strongly correlated with HV at the polygenic p<0.50 inclusion (r=0.08, 
p=0.04) and polygenic p<1 inclusion (r=0.07, p=0.05). Polygenic scores for TBV at the 
polygenic p<0.01 inclusion was correlated .08 with TBV (p=0.02). For WMH, correlations of 
0.08 and 0.09 (p<0.05) were observed at p<0.05, p<0.50 and p<1 polygenic inclusion 
thresholds. All BI polygenic score correlations showed correlational p-values greater than 
0.05 with BI. Exclusion of stroke cases did not alter the polygenic score effects, thus, 
subsequent results are reported for the larger sample to reduce the standard error of the 
estimates. 
Correlation between MRI and cognitive traits in LBC1936  
Phenotypic correlations between MRI traits and the main cognitive traits of interest in the 
LBC1936 (n ranged 570 to 629) are shown in Supplementary Table 3. With the exception of 
HV, all brain MRI traits were significantly correlated with at least one cognitive trait. BI 
correlated significantly (negatively) with all cognitive traits (n ranged 625 to 629) and TBV 
correlated significantly (positively) with all traits except NART (n ranged 619 to 623).  
Polygenic prediction of cognitive traits in all cohorts 
Meta-analysis results of the correlations between the brain MRI polygenic scores (at 
differing polygenic p-value inclusion intervals) and cognitive measures are shown in Table 1. 
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The only significant correlations (at the corrected alpha level) to demonstrate consistency 
across differing polygenic p-value threshold scores were for HV with MHT11 and MHT in old 
age (at polygenic p<0.50 and 1 thresholds). For MHT11, the correlational p-value was .003 
and for MHT, it was .003. A negative correlation was observed such that a smaller HV was 
related to better MHT scores. Forest plots for these variables (only measured in the LBC 
samples) and for a comparable measure (general cognitive ability) in all three cohorts are 
shown in Supplementary Figure 1. For TBV, heterogeneity was found between cohort 
estimates for DS, MHT11, and MHT.  
TABLE 1 ABOUT HERE 
Discussion 
Our study showed that MRI ICV polygenic scores derived from GWA results on around 
10,000 individuals (CHARGE) were predictive of variance in ICV in 624 subjects aged 72. On a 
phenotypic level, BI and WMH were negatively correlated with cognitive measures in this 
cohort, whereas the cranial and TBV measures were positively correlated. A meta-analysis 
of this and another elderly cohort showed HV polygenic scores were negatively correlated 
with the same general cognitive ability test measured in childhood and old age, explaining 
up to 1% of cognitive score variance. No other brain MRI polygenic scores were significantly 
associated with any other cognitive traits in the meta-analyses including all three Scottish 
cohorts. 
This is the first study to test whether the SNP effects reported in current GWA studies of 
brain MRI traits are predictive of variance in these traits in an independent sample. At a 
significance level corrected for multiple testing, we confirm this for ICV, and for other traits 
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(WMH, TBV, and HV) at an unadjusted alpha level of .05. The amount of variance explained 
by these polygenic effects, although small, is consistent with other polygenic prediction 
studies of psychiatric and disease traits and is argued to increase with increases in size of 
the genome-wide association samples on which prediction is based (Dudbridge 2013). The 
lack of polygenic prediction for BI is likely due to the small number of individuals in our 
sample with BI (14.8%); as a dichotomous variable this analysis was less powered than those 
of continuous traits.  
HV polygenic scores showed the strongest positive correlations with HV at polygenic p<0.5 
and p<1 inclusion thresholds (although not significant at a corrected alpha level). It was at 
these thresholds that we observed a significant (negative) correlation (at a corrected alpha 
level) between polygenic variation in HV and phenotypic variation in MHT despite a lack of 
association between phenotypic variation in HV and MHT. This is an interesting finding given 
that in young adulthood, HV shows a negative phenotypic correlation at least with measures 
of memory, an aspect of general cognitive ability. Incomplete synaptic pruning during 
childhood and adolescence has been offered as an explanation for the negative association 
between HV and cognition in earlier life (Foster et al. 1999); and if genes influence pruning 
then it might be that this variation is driving the negative correlation between HV polygenic 
scores and general cognitive ability in our sample.  
Alternatively, the HV polygenic score derived in our study might not be a valid measure of 
variation in HV because it did not significantly predict HV, therefore, any correlation with 
cognition could be a false positive finding. That a similar measure of general cognitive ability 
was not found to be associated with HV polygenic scores in the meta-analysis of all cohorts 
further supports this finding representing type 1 error. If it is important for the independent 
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prediction samples to closely match the samples used in the GWA study on which polygenic 
scores are based, then the LBC samples more closely matched the brain MRI GWAS samples 
in age (being elderly), whereas GS:SFHS was predominantly comprised of individuals under 
the age of 60 years (62%). The polygenic scores would therefore represent genetic effects 
that are important in old age, so it follows that prediction is going to be more reliable in 
older adults. However, the observation in the LBC samples that HV polygenic scores did not 
predict vocabulary or the general cognitive factor (results not shown), which are strongly 
correlated with MHT scores again points to type 1 error. 
In conclusion, polygenic effects on MRI ICV, determined in a relatively small GWA study, 
were predictive of phenotypic trait variation in ICV in an independent sample. The lack of 
association between ICV polygenic scores and cognitive ability in the larger meta-analysis 
sample might suggest that other types of genetic variants (e.g., rare, structural) explain their 
genetic covariance. Larger GWA studies of WMH, TBV, HV and BI will likely improve the 
polygenic prediction of these traits in independent samples. Polygenic scores based on 
these larger studies should then be investigated in relation to cognition. Improvements in 
the harmonization of imaging measures across studies will also enable GWA results for 
other brain MRI measures such as laterality to be included. 
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Table 1. Meta-analysis Standardised Betas (SE) between MRI Trait Polygenic Scores and Cognitive Traits. Bolded Rows Indicate 
Polygenic Scores that Significantly Predicted the Accompanying MRI Phenotype and for which we would expect significant correlations. 
 
p< Digit 
Symbol 
Verbal 
Fluency 
Logical 
Memory 
Vocabul-
ary 
General 
Factor 
MHT11 MHT  
 (N= 8020) (N= 8250) (N= 8249) (N= 8212) (N= 8115) (N= 1411) (N= 1498) 
BI        
.01 0(.01) 0(.01) 0(.01) 0(.01) 0(.01) -.06(.06)  ̾ -.04(.03) 
.05 0(.01) .03(.02) 0(.01) -.01(.01) .01(.01) -.02(.03) .03(.03) 
.10 -.01(.01) .03(.03) ̾ -.01(.01) -.02(.01) 0(.02) -.05(.05) 0(.03) 
.50 -.02(.01) .01(.02) -.01(.01) -.03(.01) -.02(.01) -.04(.03) -.02(.03) 
1 -.01(.01) .02(.02) -.01(.01) -.02(.01) -.01(.02) -.04(.03) 0(.03) 
WMH        
.01 -.01(.01) .01(.01) 0(.01) 0(.01) 0(.01) -.01(.03) 0(.03) 
.05 .01(.01) .01(.01) 0(.01) .01(.01) .01(.01) -.01(.04) 0(.05) 
.10 0(.01) 0(.01) -.02(.01) -.01(.01) -.01(.01) -.05(.05) -.03(.03) 
.50 -.01(.01) 0(.01) -.02(.01) -.01(.01) -.02(.01) -.03(.04) -.03(.04) 
1 -.01(.01) 0(.01) -.02(.01) -.01(.01) -.02(.01) -.02(.04) -.02(.03) 
ICV        
.01 -.01(.01) 0(.01) -.02(.01) 0(.01) -.01(.01) .02(.03) -.03(.03) 
.05 0(.01) .01(.02) -.01(.01) 0(.01) 0(.01) .03(.03) -.03(.03) 
.10 0(.02) 0(.01) 0(.01) .01(.01) .01(.01) .04(.03) -.01(.03) 
.50 0(.02) .01(.01) 0(.01) .01(.01) .01(.01) .02(.03) -.02(.03) 
1 .01(.02) .01(.01) 0(.01) .01(.01) .01(.01) .01(.03) -.02(.03) 
HV        
.01 -.02(.02) 0(.02) -.01(.01) -.01(.04) -.01(.02) -.04(.03) -.07(.03)* 
.05 0(.01) 0(.01) -.02(.02) -.01(.01) -.01(.01) -.04(.03) -.05(.03)* 
.10 -.01(.02) 0(.01) -.01(.01) -.01(.01) 0(.01) -.05(.03) -.05(.03)* 
.50 -.02(.03) 0(.01) -.02(.02) -.03(.03) -.02(.02) -.08(.03)** -.08(.03)** 
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1 -.03(.03)  ̾ 0(.01) -.02(.02) -.02(.02) -.02(.03) -.08(.03)** -.08(.03)** 
TBV        
.01 .05(.03) ̾ .02(.01) 0(.01) .01(.02) .02(.03) -0.01(.09)  ̾ 0(.05) 
.05 .04(.03) .02(.01)* 0(.01) .01(.01) .03(.01)* -0.02(.08)  ̾ -0.04(.07)  ̾
.10 .04(.03) ̾ 0(.01) -.01(.01) -.03(.03) .01(.01) -0.02(.08)  ̾ -0.03(.07)  ̾
.50 .05(.03) ̾ 0(.01) 0(.01) .02(.01) .03(.02) 0(.07) ̾ -0.01(.07)  ̾
1 .04(.03) ̾ .01(.01) 0(.01) .03(.02) .03(.03) 0(.08) ̾ -0.02(.08)  ̾
*p<.05; **p<.01 
̾sample heterogeneity (p<.05): 
BI: MHT11 (p<.01 inclusion), LBC1936 (r=-.01), LBC1921 (r=-.13*); Verbal Fluency (p<.1 inclusion) GS (r=0), LBC1936 (r=.07*), 
LBC1921 (r=.02) 
HV: Digit Symbol (p<1 inclusion), GS (r=.01), LBC1936 (r=-.09*), LBC1921 (r=-.01) 
TBV: Digit Symbol (p<.01, .1, .5, 1), GS (r=.01, 0, .01, .01), LBC1936 (r=.11*, .09*, .10*, .09*), LBC1921 (r=.04, .03, .05, .05); 
MHT11 (p<.01, .05, .1, .5, 1), LBC1936 (r=.07*, .05, .06, .07*, .07*), LBC1921 (r=-.10*, -.11*, -.11, -.08, -.08); MHT (p<.05, .1, 
.5, 1), LBC1936 (r=.02, .03, 06, .06), LBC1921 (r=-.11*, -.11*, -.09*, -.10*) 
 
